Autologous Serum Eydrops in Inpatients

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

1 post / 0 new
Timothy Lesar
Timothy Lesar's picture
Offline
Last seen: 4 years 6 months ago
Joined: 12/23/2019 - 12:19
Autologous Serum Eydrops in Inpatients

We have been asked to evaluate the possibility of preparing autologous serum eyedrops (SED). There are numerous issues ranging from regulatory (in NY SED use is considered a blood derivative "re-infusion"), preparation standards - eg USP <797>, to infection control considerations.
If you do prepare SED in your pharmacy would you be willing to share your procedures?

If you allow use of SED in inpatients (either patient "own" or institutionally prepared), how do you handle specifics of dispensing, storage and infectious disease exposure risk to staff and environment?

Any assistance is greatly appreciated!

Tim Lesar
Albany Medical Center

Tags: